SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-12 |
| Reported value | $86,479,405 |
| Positions | 32 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| X4 PHARMACEUTICALS INC | XFOR | COM NEW | $32,365,860 | 6,930,591 |
| EMPERY DIGITAL INC | EMPD | COM NEW | $10,432,028 | 2,930,345 |
| NERVGEN PHARMA CORP | NGEN | COM | $8,240,000 | 4,000,000 |
| PRECISION BIOSCIENCES INC | DTIL | COM NEW | $6,100,091 | 776,093 |
| CLENE INC | CLNN | COM NEW | $5,641,254 | 916,532 |
| ANNOVIS BIO INC | ANVS | COM | $4,466,745 | 2,401,476 |
| LANTERN PHARMA INC | LTRN | COM | $3,513,930 | 842,669 |
| AMC ENTMT HLDGS INC | AMC | CL A NEW | $3,256,682 | 1,714,043 |
| TENAYA THERAPEUTICS INC | TNYA | COM | $2,855,228 | 3,863,115 |
| ONE AND ONE GREEN TECHNOLOGI | Unresolved | USD CL A ORD SHS | $1,538,646 | 761,706 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.